Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
120717512 | 12071751 | 2 | F | 2015 | 20160811 | 20160212 | 20160826 | EXP | US-WEST-WARD PHARMACEUTICALS CORP.-US-H14001-16-00210 | WESTWARD | 0.00 | F | Y | 53.50000 | KG | 20160826 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
120717512 | 12071751 | 1 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | Y | 76099 | ||||||||||
120717512 | 12071751 | 2 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | N | 75036 | 60 | MG/M**2 | ||||||||
120717512 | 12071751 | 3 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | N | 75036 | ||||||||||
120717512 | 12071751 | 4 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | N | 75036 | ||||||||||
120717512 | 12071751 | 5 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | Y | N | 74290 | 120 | MG/M**2 | |||||||
120717512 | 12071751 | 6 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | Y | N | 74290 | |||||||||
120717512 | 12071751 | 7 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | Y | N | 74290 | |||||||||
120717512 | 12071751 | 8 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 0 | |||||||||||
120717512 | 12071751 | 9 | C | ALBUTEROL. | ALBUTEROL | 1 | Respiratory (inhalation) | 0 | 2 | DF | Q6H | ||||||||
120717512 | 12071751 | 10 | C | FOLVITE | FOLIC ACID | 1 | Oral | 0 | |||||||||||
120717512 | 12071751 | 11 | C | ATIVAN | LORAZEPAM | 1 | Oral | 0 | 1 | DF | BID | ||||||||
120717512 | 12071751 | 12 | C | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | Oral | 0 | |||||||||||
120717512 | 12071751 | 13 | C | KLORCON M20 | 2 | Unknown | 0 | ||||||||||||
120717512 | 12071751 | 14 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 0 | |||||||||||
120717512 | 12071751 | 15 | C | ROXICODONE | OXYCODONE HYDROCHLORIDE | 1 | Oral | 0 | 2 | DF | Q3H | ||||||||
120717512 | 12071751 | 16 | C | ROXANOL | MORPHINE SULFATE | 1 | Oral | 0 | 1 | DF | BID | ||||||||
120717512 | 12071751 | 17 | C | ROXANOL | MORPHINE SULFATE | 1 | Oral | 0 | .5 | ML | |||||||||
120717512 | 12071751 | 18 | C | DOXYCYCLINE. | DOXYCYCLINE | 1 | Unknown | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
120717512 | 12071751 | 1 | Lung neoplasm malignant |
120717512 | 12071751 | 2 | Lung neoplasm malignant |
120717512 | 12071751 | 5 | Lung neoplasm malignant |
120717512 | 12071751 | 8 | Product used for unknown indication |
120717512 | 12071751 | 9 | Wheezing |
120717512 | 12071751 | 10 | Product used for unknown indication |
120717512 | 12071751 | 11 | Anxiety |
120717512 | 12071751 | 12 | Product used for unknown indication |
120717512 | 12071751 | 13 | Product used for unknown indication |
120717512 | 12071751 | 14 | Product used for unknown indication |
120717512 | 12071751 | 15 | Pain |
120717512 | 12071751 | 16 | Pain |
120717512 | 12071751 | 18 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
120717512 | 12071751 | HO |
120717512 | 12071751 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
120717512 | 12071751 | Arthralgia | |
120717512 | 12071751 | Cough | |
120717512 | 12071751 | Dysphonia | |
120717512 | 12071751 | Fatigue | |
120717512 | 12071751 | Malignant neoplasm progression | |
120717512 | 12071751 | Neutropenia | |
120717512 | 12071751 | Oedema peripheral | |
120717512 | 12071751 | Pancytopenia | |
120717512 | 12071751 | Pyrexia | |
120717512 | 12071751 | Respiratory failure | |
120717512 | 12071751 | Somnolence | |
120717512 | 12071751 | Stress | |
120717512 | 12071751 | Stress cardiomyopathy | |
120717512 | 12071751 | Vulvovaginal mycotic infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
120717512 | 12071751 | 1 | 2015 | 20151001 | 0 | |
120717512 | 12071751 | 2 | 20150603 | 20150603 | 0 | |
120717512 | 12071751 | 3 | 20150607 | 20150607 | 0 | |
120717512 | 12071751 | 5 | 20150603 | 20150603 | 0 | |
120717512 | 12071751 | 6 | 20150608 | 20150608 | 0 | |
120717512 | 12071751 | 7 | 20151001 | 0 | ||
120717512 | 12071751 | 15 | 20160113 | 0 | ||
120717512 | 12071751 | 16 | 20160113 | 0 | ||
120717512 | 12071751 | 18 | 201511 | 0 |